EUVIMEDEUVIMED entdecken
Crossref

Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline

Qian Liu iD, Lixin Lun, Meng Sun, Zekun Wang iD, Yuan Qu, Xiaodong Huang, Xuesong Chen, Jingbo Wang iD, Jianghu Zhang, Kai Wang, Runye Wu, Ye Zhang iD und 2 weitere

Head & Neck · 2023

DOI: 10.1002/hed.27462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Qian Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sci…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Paranasal Sinus Neoplasms. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying the lymph node target volume in patients with node‐negative sinonasal squamous cell carcinoma (SNSCC) crossing the midline poses a challenge. This study aims to address this.

Methods

We retrospectively reviewed clinically N0 patients with tumors crossing the midline who received elective neck irradiation (ENI) from two centers between 1999 and 2019. The main endpoint was regional relapse‐free survival (RRFS).

Results

We included 104 patients: 64 received bilateral ENI, and 40 received ipsilateral‐only ENI (median follow‐up time was 89.99 and 95.01 months, respectively). At 5 years, the RRFS rates were comparable (57.68% vs. 55.83%, p = 0.372), as were the contralateral RRFS (57.68% vs. 61.62%, p = 0.541). Five‐year OS, LRFS, and DMFS showed no significant difference between two groups.

Conclusions

Our findings provide preliminary evidence suggesting the potential for avoiding contralateral ENI in SNSCC patients with midline crossing tumors who undergo ipsilateral ENI, covering at least level II. Validation through future prospective studies is necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellParanasal Sinus NeoplasmsHumansRetrospective StudiesProspective StudiesFeasibility StudiesLymphatic MetastasisNeoplasm StagingNeoplasm Recurrence, LocalSquamous Cell Carcinoma of Head and Neck

Stichwörter der Autor:innen

contralateral regional relapse-free survivalcrossing the midlineelective neck irradiationregional relapse-free survivalsinonasal squamous cell carcinoma

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Head and Neck Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.

ORCID-Profile: Qian Liu, Zekun Wang, Jingbo Wang, Ye Zhang, Junlin Yi, Jingwei Luo

Zitieren

APA

Liu, Q., Lun, L., Sun, M., Wang, Z., Qu, Y., Huang, X., Chen, X., Wang, J., Zhang, J., Wang, K., Wu, R., Zhang, Y., Yi, J., & Luo, J. (2023). Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline. Head & Neck. https://doi.org/10.1002/hed.27462

Vancouver

Liu Q, Lun L, Sun M, Wang Z, Qu Y, Huang X, et al. Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline. Head & Neck. 2023. doi:10.1002/hed.27462

BibTeX
@article{Liu2023,
  author = {Liu, Qian and Lun, Lixin and Sun, Meng and Wang, Zekun and Qu, Yuan and Huang, Xiaodong and Chen, Xuesong and Wang, Jingbo and Zhang, Jianghu and Wang, Kai and Wu, Runye and Zhang, Ye and Yi, Junlin and Luo, Jingwei},
  title = {Feasibility of omitting contralateral neck irradiation in patients with node‐negative sinonasal squamous cell carcinoma crossing the midline},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27462}
}
Kostenlos starten →